Harnessing mobile devices to create a sustainable way of delivering eye care at scale, through COVID and beyond

Okulo Ltd(交易名称为Okko Health)开发用于家庭视力监测的智能手机软件。该项目旨在推动技术系统和相应患者路径的开发，以允许人工智能驱动的家庭视力监测，否则患者将不得不来医院眼科诊所就诊。该项目将从APP数据和研究方法中开发诊断生物标记物，以优化其在NHS和其他地方的应用。这将增加卫生保健系统的环境可持续性和财务可持续性。这回应了我们现在需要对远离医院诊所的视力进行分流/监测的严峻挑战。大规模取消面对面预约意味着，如果病情恶化不能及时发现并进行治疗，我们的患者群体将面临失明。在该项目中，我们将与NHS单位和布里斯托尔大学的工作人员密切合作。拟议的项目不仅仅是开发互联和智能的技术，它还涉及与患者及其家人、医生、护士和医院管理系统共同设计一种全新的数字护理途径，当我们需要它时，它将彻底改变我们所有人的眼睛护理体验。

Okulo Ltd (trading as OKKO Health) develop smartphone software for home-monitoring of vision.This project is to drive the development of a technological system and corresponding patient pathway to allow AI-driven home-monitoring of vision for patients who would otherwise have had to come for in-person hospital eye clinic appointments. This project will develop diagnostic biomarkers from app data and research ways to optimise their uptake in the NHS and beyond. This will increase both the environmental sustainability and the financial sustainability of the NHS.This responds to the acute COVID challenge that we now need to triage/monitor vision away from hospital clinics. The mass cancellation of in-person appointments means that our patient population face sight loss if a deterioration in their condition is not picked up early enough in time for treatment.In the project we will work closely with NHS units and with University of Bristol staff. The proposed project isn't just about developing connected and clever technology, but it's about co-designing with patients and their families, and doctors, nurses and hospital administration systems a brand new digital pathway of care that will revolutionise the experience of eye care for all of us when we need it.